Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $8.46 million. The enterprise value is -$32.77 million.
| Market Cap | 8.46M |
| Enterprise Value | -32.77M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 12.59 million shares outstanding. The number of shares has increased by 243.85% in one year.
| Current Share Class | 12.59M |
| Shares Outstanding | 12.59M |
| Shares Change (YoY) | +243.85% |
| Shares Change (QoQ) | +264.19% |
| Owned by Insiders (%) | 8.92% |
| Owned by Institutions (%) | 11.88% |
| Float | 7.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,675.58 |
| Forward PS | 6.75 |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.55
| Current Ratio | 13.55 |
| Quick Ratio | 13.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.15% and return on invested capital (ROIC) is -30.99%.
| Return on Equity (ROE) | -46.15% |
| Return on Assets (ROA) | -27.73% |
| Return on Invested Capital (ROIC) | -30.99% |
| Return on Capital Employed (ROCE) | -33.73% |
| Weighted Average Cost of Capital (WACC) | 12.98% |
| Revenue Per Employee | $648 |
| Profits Per Employee | -$1.54M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -59.17% in the last 52 weeks. The beta is 1.59, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -59.17% |
| 50-Day Moving Average | 0.70 |
| 200-Day Moving Average | 0.85 |
| Relative Strength Index (RSI) | 54.60 |
| Average Volume (20 Days) | 46,977 |
Short Selling Information
The latest short interest is 41,083, so 0.33% of the outstanding shares have been sold short.
| Short Interest | 41,083 |
| Short Previous Month | 60,595 |
| Short % of Shares Out | 0.33% |
| Short % of Float | 0.53% |
| Short Ratio (days to cover) | 0.65 |
Income Statement
In the last 12 months, APRE had revenue of $5,185 and -$12.31 million in losses. Loss per share was -$0.60.
| Revenue | 5,185 |
| Gross Profit | -6.72M |
| Operating Income | -13.22M |
| Pretax Income | -12.31M |
| Net Income | -12.31M |
| EBITDA | -13.20M |
| EBIT | -13.22M |
| Loss Per Share | -$0.60 |
Balance Sheet
The company has $41.23 million in cash and no debt, with a net cash position of $41.23 million or $3.27 per share.
| Cash & Cash Equivalents | 41.23M |
| Total Debt | n/a |
| Net Cash | 41.23M |
| Net Cash Per Share | $3.27 |
| Equity (Book Value) | 39.20M |
| Book Value Per Share | 3.10 |
| Working Capital | 38.82M |
Cash Flow
In the last 12 months, operating cash flow was -$12.17 million and capital expenditures -$15,400, giving a free cash flow of -$12.18 million.
| Operating Cash Flow | -12.17M |
| Capital Expenditures | -15,400 |
| Depreciation & Amortization | 22,032 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.18M |
| FCF Per Share | -$0.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | -255,025.52% |
| Pretax Margin | -237,362.80% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -243.85% |
| Shareholder Yield | -243.85% |
| Earnings Yield | -141.66% |
| FCF Yield | -140.23% |
Analyst Forecast
The average price target for APRE is $3.55, which is 428.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.55 |
| Price Target Difference | 428.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 91.63% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -9.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.6 |
| Piotroski F-Score | 2 |